Skip to main content
Caplight Logo









Nuroflux

Nuroflux

Private
SydneyHealthcare & Life Scienceshttps://nuroflux.com/

Last Round

Accelerator

May 11, 2022

Total Funding Raised

$129,000

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Nuroflux is a medical device company developing a wearable to non-invasively monitor brain activity and brain blood flow for stroke patients.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Healthcare Analytics, Health IoT, Clinical Trials

Business Model

B2B

Customer Profile

Hardware + Subscription, Hardware Sales, Subscription SaaS

AI Layer

Application

Keywords

continuous brain monitoringstroke monitoringwearable medical deviceneuromonitoringbrain blood flow monitoringmedtechelectroencephalographyEEGnon-invasive monitoringmedical AIclinical decision supporthealth IoTIoMTelectrocardiographyECG

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nuroflux Comparables

Compare Nuroflux with similar companies based on industry and business-model similarity.

Nuroflux comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Zeit Medical
85%
Time is Brain
84%
Neuralert Technologies Inc.
78%

Nuroflux Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorMay 11, 2022
GrantDec 14, 2021

Key People

Founding team and executive leadership

David Almeida Cardoso

Co-Founder and Chief Business Officer

Founding Team

Sam van Bohemen

Co-Founder, CEO & CTO

Founding Team

Nuroflux Investors

Notable investors and investment history

Nuroflux investors
InvestorRounds
Cerebral Palsy AllianceAccelerator
NSW GovernmentGrant
RemarkableAccelerator
UNSW FoundersAccelerator
The George Institute for Global HealthAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors grew 424% MoM, from 278 to 1.5K.

  • Apr 20, 2026

    Monthly visitors grew 146% MoM, from 401 to 988.

Nuroflux Filings

Explore SEC and related filing metadata, where available.

Nuroflux filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Nuroflux's valuation, stock price, and market status.

Is Nuroflux a public or private company?

Nuroflux is a private company.

What is the current stock price of Nuroflux?

Nuroflux is a private company with no public stock price. No recent secondary market data is available.

How much is Nuroflux worth (valuation)?

Valuation information for Nuroflux is not publicly available.

Can I buy Nuroflux stock?

Nuroflux shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Nuroflux's last funding round?

Funding round information for Nuroflux is not publicly available.

Who are the main investors in Nuroflux?

Investor information for Nuroflux is not publicly disclosed.

Will Nuroflux IPO soon?

No public IPO plans have been announced for Nuroflux.

How can I track Nuroflux secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Nuroflux's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSydney
Employee Range4
Year Founded2020
Last FundingMay 11, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?